HMNC Brain Health (HMNC), a biotech company pioneering the development of personalised therapies in psychiatry powered by predictive companion diagnostics, has received an additional EUR9 million from its current investors. The supplemental investment brings the total raised to date to EUR28 million and will secure HMNC’s financial position in advance
Patchwork Health, a healthcare staffing platform founded by doctors, has raised GBP3.5 million in a funding round led by Praetura Ventures and BMJ New Ventures. Founded in 2016 by NHS doctors Anas Nader and Jing Ouyang, Patchwork Health’s workforce technology and services are used by over 70 NHS sites to
A medtech company, which has developed a new biomaterial used for 3D printing medical implants, has completed a GBP1.6 million funding round. The investment into Nottingham-based 4D Biomaterials was led by DSW Ventures and backed by the MEIF Proof of Concept & Early Stage Fund, which is managed by Mercia and
Relief Therapeutics Holding (Relief), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, has closed a definitive agreement to acquire all outstanding shares of AdVita Lifescience (AdVita), a Germany-based, privately held pharmaceutical company developing effective products and strategies to improve the treatment and
NewQuest Capital Partners (NewQuest), a dedicated secondary private equity platform focused on the Asia-Pacific region, has acquired a minority interest in Kids Clinic India Private Limited, operator of the Cloudnine chain of hospitals across India. The stake has been acquired through a combination of a primary investment and acquisition of
CEVEC Pharmaceuticals (CEVEC), a provider of high-performance cell technology for scalable manufacturing of advanced bio-therapeutics, has closed an internal growth financing round. Being profitable in 2020, the company plans to use the funds to accelerate company growth and to further build up cell line development capacities to address the growing
Novo Holdings, a leading international life science investor, has led a USD118 million Series C financing in new portfolio company Genomatica, which harnesses biology to remake everyday products and materials with a reduced environmental impact. The funding will be used to accelerate the global commercialisation and expansion of Genomatica’s sustainable
HIG Capital (HIG) has sold portfolio company US Medical Supply (US MED to Advanced Diabetes Supply (ADS), a portfolio company of Court Square Capital Partners Inc. Terms of the transaction have not been disclosed. US MED is among the largest and fastest growing direct-to-consumer specialty distributors of Continuous Glucose Monitors
Elvie, a global health and lifestyle brand developing products for women, has raised GBP58 million (USD80 million) in a Series C funding round. The round was led by BGF, with further investment from funds and accounts managed by BlackRock Private Equity Partners (BlackRock) and a consortium including Hiro Capital and
Private equity firm TA Associates has completed a majority growth investment in Elos Medtech AB (NASDAQ STOCKHOLM: ELOS B), an innovative full-service contract development and manufacturing organisation (CDMO) in the global medical device market. Founded in 1923, Elos Medtech is headquartered in Gothenburg, Sweden with operations being conducted at facilities
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
